Survival from cancer of the oesophagus in England and Wales up to 2001
2008
Survival from Oesophageal Cancer in England and Wales
Sample size: 1002
Commentary
Evidence: moderate
Author Information
Author(s): S Rao, D Cunningham
Primary Institution: Royal Marsden Hospital
Conclusion
The study indicates that survival rates for oesophageal cancer have improved due to advancements in treatment and surgical practices.
Supporting Evidence
- Median survival for patients undergoing curative resection was 25 months.
- Neoadjuvant chemotherapy plus surgery improved 2-year survival rates from 34% to 43%.
- Chemotherapy has shown a survival advantage over best supportive care for advanced oesophageal tumours.
Takeaway
Doctors have found better ways to treat oesophageal cancer, which helps more people live longer after being diagnosed.
Methodology
The study analyzed survival rates and treatment outcomes for patients with oesophageal cancer in England and Wales.
Limitations
The data may not reflect the impact of newer treatments introduced after 2001.
Participant Demographics
The study included patients with locally advanced unresectable or metastatic oesophageal cancer.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI: 0.66–0.97
Statistical Significance
p=0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website